# Commission Implementing Regulation (EU) 2016/576 of 14 April 2016 amending Regulation (EU) No 37/2010 as regards the substance ‘rafoxanide’ (Text with EEA relevance), Annex

Extent: E+W+S+N.I.

In Table 1 of the Annex to Regulation (EU) No 37/2010, the entry for the substance ‘rafoxanide’ is replaced by the following:
Pharmacologically active Substance
Marker residue
Animal Species
MRL
Target Tissues
Other Provisions (according to Article 14(7) of Regulation (EC) No 470/2009)
Therapeutic Classification
‘Rafoxanide
Rafoxanide
Bovine
30 μg/kg
30 μg/kg
10 μg/kg
40 μg/kg
Muscle
Fat
Liver
Kidney
NO ENTRY
Antiparasitic agents/Agents against endoparasites’
Ovine
100 μg/kg
250 μg/kg
150 μg/kg
150 μg/kg
Muscle
Fat
Liver
Kidney
Bovine, ovine
10 μg/kg
Milk
Provisional MRL shall expire on 31 December 2017

---
Source: https://www.legislation.gov.uk/eur/2016/576/annex (the official version)
Page: https://openlegislation.uk/eu-regulation-2016-576/annex
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.